192 related articles for article (PubMed ID: 29204973)
1. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
[TBL] [Abstract][Full Text] [Related]
2. One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease.
Alssema M; Newson RS; Bakker SJ; Stehouwer CD; Heymans MW; Nijpels G; Hillege HL; Hofman A; Witteman JC; Gansevoort RT; Dekker JM
Diabetes Care; 2012 Apr; 35(4):741-8. PubMed ID: 22338109
[TBL] [Abstract][Full Text] [Related]
3. External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.
Asgari S; Moosaie F; Khalili D; Azizi F; Hadaegh F
J Transl Med; 2020 Jul; 18(1):267. PubMed ID: 32615996
[TBL] [Abstract][Full Text] [Related]
4. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures.
Chen L; Magliano DJ; Balkau B; Colagiuri S; Zimmet PZ; Tonkin AM; Mitchell P; Phillips PJ; Shaw JE
Med J Aust; 2010 Feb; 192(4):197-202. PubMed ID: 20170456
[TBL] [Abstract][Full Text] [Related]
5. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
6. The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus.
van der Leeuw J; van Dieren S; Beulens JW; Boeing H; Spijkerman AM; van der Graaf Y; van der A DL; Nöthlings U; Visseren FL; Rutten GE; Moons KG; van der Schouw YT; Peelen LM
Heart; 2015 Feb; 101(3):222-9. PubMed ID: 25256148
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
[TBL] [Abstract][Full Text] [Related]
8. External validation of prognostic models for chronic kidney disease among type 2 diabetes.
Saputro SA; Pattanateepapon A; Pattanaprateep O; Aekplakorn W; McKay GJ; Attia J; Thakkinstian A
J Nephrol; 2022 Jul; 35(6):1637-1653. PubMed ID: 34997924
[TBL] [Abstract][Full Text] [Related]
9. [Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo].
Li QQ; Liang JY; Wang JM; Shen P; Sun YX; Chen Q; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):945-952. PubMed ID: 35725354
[No Abstract] [Full Text] [Related]
10. External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study.
Al Oraimi F; Al Rawahi A; Al Harrasi A; Albusafi S; Al-Manji LM; Alrawahi AH; Al Salmani AA
BMJ Open; 2023 Nov; 13(11):e071369. PubMed ID: 37968004
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
Wilkinson L; Yi N; Mehta T; Judd S; Garvey WT
PLoS Med; 2020 Aug; 17(8):e1003232. PubMed ID: 32764746
[TBL] [Abstract][Full Text] [Related]
12. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
Bundy JD; Rahman M; Matsushita K; Jaeger BC; Cohen JB; Chen J; Deo R; Dobre MA; Feldman HI; Flack J; Kallem RR; Lash JP; Seliger S; Shafi T; Weiner SJ; Wolf M; Yang W; Allen NB; Bansal N; He J;
J Am Soc Nephrol; 2022 Mar; 33(3):601-611. PubMed ID: 35145041
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
[No Abstract] [Full Text] [Related]
14. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL
JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801
[TBL] [Abstract][Full Text] [Related]
15. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
16. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
[TBL] [Abstract][Full Text] [Related]
17. Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors.
Ye W; Ding X; Putnam N; Farej R; Singh R; Wang D; Kuo S; Kong SX; Elliott JC; Lott J; Herman WH
J Diabetes Complications; 2022 May; 36(5):108180. PubMed ID: 35339377
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
19. A prediction model on incident ESKD among individuals with T2D and CKD.
Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
J Diabetes Complications; 2023 Apr; 37(4):108450. PubMed ID: 36871314
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
